MAGNESIOBOI 48.62 mg TABLETS
Ask a doctor about a prescription for MAGNESIOBOI 48.62 mg TABLETS
How to use MAGNESIOBOI 48.62 mg TABLETS
Introduction
Leaflet: information for the user
Magnesioboi 48.62 mg tablets
Magnesium
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.
- Keep this leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
- You should consult a doctor if your condition worsens or does not improve after 7 days.
Contents of the leaflet
- What Magnesioboi is and what it is used for
- What you need to know before taking Magnesioboi
- How to take Magnesioboi
- Possible side effects
- Storage of Magnesioboi
- Package contents and additional information
1. What Magnesioboi is and what it is used for
This medication contains magnesium lactate. It belongs to a group of medications called "mineral supplements".
It is used for the prevention of magnesium deficiency states due to diets poor in vegetables, whole grains, and legumes that manifest with weakness and muscle cramps that may occur in adults and children over 12 years old.
You should consult a doctor if your condition worsens or does not improve after 7 days.
2. What you need to know before taking Magnesioboi
Do not take Magnesioboi:
- if you are allergic to magnesium lactate or any of the other components of this medication (listed in section 6),
- if you have severe renal insufficiency (reduced kidney function),
- if you have or have had heart diseases such as angina pectoris or myocardial infarction,
- if you have or have had a diabetic coma (loss of consciousness due to excessively high or low blood sugar levels),
- if you have been diagnosed with myasthenia gravis (an autoimmune neuromuscular disease),
- if you suffer from chronic diarrhea or have been diagnosed with inflammatory bowel disease (ulcerative colitis),
- if you have had an intestinal intervention (ileostomy),
- if you have symptoms of appendicitis: abdominal pain (pain around the navel) that increases in intensity and moves to the lower right part of the abdomen as the process evolves. This pain may be accompanied by loss of appetite, nausea, vomiting, and low-grade fever.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Magnesioboi.
- The continued use of this medication may cause hypermagnesemia (high magnesium levels in the blood) characterized by nausea, vomiting, respiratory depression (weak breathing), and central nervous system depression (symptoms can range from numbness to coma), hyperreflexia (exaggerated reflexes), muscle weakness, and certain cardiovascular effects such as low blood pressure, decreased heart rate, and cardiac arrest.
- Taking this medication on an empty stomach may cause diarrhea.
- Patients with kidney disease should consult their doctor before taking this medication.
Children and adolescents
Do not administer to children under 12 years old unless advised by a doctor.
Elderly patients
In patients over 65 years old who suffer from reduced kidney function, the dose and frequency of magnesium salt administration should be adjusted by the doctor according to the degree of renal function reduction.
Using Magnesioboi with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
This medication reduces the absorption of
- Antibiotics such as tetracyclines (doxycycline, minocycline, oxytetracycline, tetracycline) and quinolones (ciprofloxacin, levofloxacino, norfloxacin, ofloxacin).
- Bisphosphonates (medications used in the treatment of osteoporosis).
The intake of Magnesioboi and these medications should be spaced at least 2 hours apart to avoid unwanted interactions.
Taking Magnesioboi with food and drinks
Excessive and prolonged consumption of products containing magnesium and calcium can cause high calcium levels in the blood. In these situations, calcium intake and foods rich in calcium, such as dairy products, should be controlled.
This medication should be taken after meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
It is recommended to cover magnesium needs with a diet rich in vegetables, whole grains, and legumes to prevent the consequences of magnesium deficiency during pregnancy.
No problems have been described in breastfed children whose mothers take magnesium at the recommended doses.
Driving and using machines
The influence of magnesium on driving and machine safety is nil or insignificant.
Magnesioboi contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
3. How to take Magnesioboi
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly. If in doubt, ask your doctor or pharmacist.
The recommended dose for adults and children over 12 years old is 1 to 2 tablets (48.62 mg to 97.24 mg of magnesium), after each of the three meals (146 mg to 292 mg of magnesium per day). The tablets should be taken with a sufficient amount of liquid.
Do not exceed the maximum recommended dose (6 tablets per day).
Elderly patients, children under 12 years old, and patients with kidney disease should consult their doctor.
This medication is administered orally.
If your symptoms worsen or do not improve within 7 days of treatment, consult your doctor.
If you take more Magnesioboi than you should
If you have taken more medication than you should, consult your doctor or pharmacist immediately.
In cases of poisoning caused by ingestion of high doses, or in patients with renal insufficiency with decreased urine production, an increase in magnesium levels in the blood may occur. In this case, the following manifestations may appear: nausea, vomiting, drowsiness, double vision, dizziness, speech problems, swallowing difficulties, muscle weakness, skin redness, low blood pressure, cardiac rhythm disorders, and cardiac arrest.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service (Telephone 91.562.04.20), indicating the medication and the amount ingested.
If you forget to take Magnesioboi
Do not take a double dose to make up for forgotten doses. Take your dose as soon as you remember and continue treatment as before.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
4. Possible side effects
Like all medications, this medication can cause side effects, although not everyone may experience them.
During the use of this medication, the following side effects have been reported, whose frequency cannot be established with precision. The most common ones are gastrointestinal disorders, such as diarrhea and vomiting, and less frequently, increased magnesium levels in the blood, which may be associated with the following discomforts: drowsiness, double vision, dizziness, muscle weakness, and low blood pressure.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
5. Storage of Magnesioboi
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the box after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
6. Package contents and additional information
Magnesioboi composition
The active ingredient is magnesium lactate. Each tablet contains 48.62 mg of magnesium, provided by 404.85 mg of magnesium lactate.
The other components (excipients) are: lactose monohydrate, macrogol 6000, sodium croscarmellose, magnesium stearate, and talc.
Product appearance and package contents
Magnesioboi is presented in the form of white-bone colored, round, biconvex tablets. Each package contains 50 tablets.
Marketing authorization holder
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Manufacturer
P&G Health Austria GmbH & Co. OG
Hösslgasse 20
9800 Spittal an der Drau
Austria
or
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Date of the last revision of this leaflet: January 2011
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
- Country of registration
- Active substance
- Prescription requiredNo
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MAGNESIOBOI 48.62 mg TABLETSDosage form: ORAL SOLUTION/SUSPENSION, 2000 mg magnesium pidolateActive substance: magnesium pidolateManufacturer: Faes Farma S.A.Prescription not requiredDosage form: ORAL SOLUTION/SUSPENSION, 200 mgActive substance: magnesium (different salts in combination)Manufacturer: Nutricion Medica S.L.Prescription requiredDosage form: TABLET, 53 mgActive substance: magnesium (different salts in combination)Manufacturer: Uriach Consumer Healthcare S.L.Prescription not required
Alternatives to MAGNESIOBOI 48.62 mg TABLETS in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to MAGNESIOBOI 48.62 mg TABLETS in Poland
Alternative to MAGNESIOBOI 48.62 mg TABLETS in Ukraine
Online doctors for MAGNESIOBOI 48.62 mg TABLETS
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MAGNESIOBOI 48.62 mg TABLETS – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
